Page 46 - 68_02

68 (2), FUNDAMENTOS DE LAS INTERACCIONES FARMACOCINÉTICAS

creased gastric pH and the bioavailability of fluconazole and ketoconazole . Ann.
Intern. Med. 114: 755-757.

(30) GOSS, T.F., PISCITELLI, S.C., SCHENTAG, J.J, (1991): Evaluation of ketoconazole
bioavailability interactions with sucralfate and ranitidine using gastric pH moni-
toring. Clin. Pharmacol. Ther. 49:128.

(31) PISCITELLI, S.C., GOSS, T.F., WILTON, J.H., D´ANDREA, D.T., GOLDSTEIN, H.,
SCHENTAG, J.J. (1991): Effects of ranitidine and sucralfate on ketoconazole
bioavailability. Antimicrob. Ag. Chemother. 35:1765-1771.

(32) WAGNER, J.G. (1966): Design and data analysis of biopharmaceutical studies in
man. Can. J. Pharm. Sci. 1:55.

(33) NEUVONEN, P.J., KIVISTÖ, K., HIRVISALO, E.L. (1988): Effects of resins and acti-
vated charcoal on the absorption of digoxin, carbamazepine and furosemide. Br. J.
Clin. Pharmacol. 25:229-233.

(34) NEUVONEN, P.J., KANNISTO, H., HIRVISALO, E.L. (1983): Effect of activated char-
coal on the absorption of tolbutamide and valproate in man. Eur. J. Clin. Pharma-
col.. 24:243-246.

(35) NEUVONEN, P.J., ELFVING, S. (1978): Reduction of absorption of digoxin, pheny-
toin and aspirin by activated charcoal. Eur. J. Pharmacol. 13:213.

(36) NEUVONEN P.J., ELONEN, E., MATTTILA,M.J. (1980): Orally given charcoal in-
creases the rate of elimination of phenobarbital, carbamazepine, phenylbutazone
and dapsone in man. Clin. Pharmacol. Ther. 27:275-276.

(37) MCELNAY, J.C., MUKHTAR, H.A., D´ARCY, P.F., TEMPLE, D.J., COLLIER, P.S.
(1982): The effect of magnesium trisilicate and kaolin on the in vivo absorption of
chloroquine. J. Trop. Med. Hyg. 85:159-163.

(38) MCELNAY, J.C., MUKHTAR, H.A., D´ARCY, P.F., TEMPLE, D.J. (1982) : In vitro
experiments on chloroquine and pyrimethamine absorption in the presence of ant-
acid constituents of kaolin. J. Trop. Med. Hyg. 85:153-158.

(39) LAWLER, D.P., HYERS, T.M. (1993): Extreme prolongation of the prothrombin
time in a patient receiving warfarin and cholestyramine. Cardiovasc. Rev. Rep.
72-74.

(40) CALDWELL, J.H., BUSH, C.A., GREENBERGER, N.J. (1971): Interruption of the
enterohepatic circulation of digitoxin by cholestyramine. J. Clin. Invest. 50:2638.

(41) CARRUTHERS, S.G., DUJOVNE, C.A. (1980): Cholestyramine and spironolactone
and their combination in digitoxin elimination. Clin. Pharmacol. Ther. 27:184.

(42 LEYDEN, J.J. (1985): Absorption of minocycline hydrochloride and tetracycline
hydrochloride. Effects of food, milk and iron. J. Am. Acad. Dermatol. 12:308-
312.

169